Pyrogen Testing Market Share and Growth Factors, Covid-19 Impact ,Analysis 2021–2025 | River Laboratories, Inc. (US) ,Lonza (Switzerland) & Merck KGaA (Germany)



 The growing focus on customised medicine, increased R&D in the pharmaceutical and biotechnology industries, rising prevalence of chronic diseases, increased awareness of food safety, and rising incidence of infectious diseases and pandemics are all driving market expansion.

The global pyrogen testing market is expected to grow at a CAGR of 12.7 percent from USD 927 million in 2020 to USD 1,689 million in 2025.

COVID-19 is a newly identified novel coronavirus that causes an infectious sickness. COVID-19, which was mostly unknown until the outbreak in Wuhan, China, in December 2019, has gone from a regional issue to a global pandemic in just a few weeks. Since the World Health Organization (WHO) proclaimed COVID-19 to be a pandemic, a number of established pharmaceutical and biopharmaceutical companies, as well as small startups, have stepped up to create medicines and vaccines to combat the infection caused by the novel coronavirus. According to the WHO, there are currently 70 vaccine candidates in development, with three of them being studied in human trials. The economic and social costs of the pandemic have spurred governments around the world to increase funding for vaccine development, resulting in a rise in the use of pyrogen testing kits in COVID-19 research.

Because of the rising prevalence of major infectious diseases and epidemics, the demand for pyrogen testing procedures has been steadily increasing over the last decade. During the projection period, demand for pyrogen testing procedures (used for endotoxin and microbial identification) is predicted to rise due to an increase in the global incidence of infectious diseases.

The APAC region is a highly profitable market for the life sciences industry. For example, India has been taking substantial steps to promote itself as the world's leading major biopharmaceutical innovation hub, including fostering public-private partnerships (PPPs) in biopharmaceutical R&D projects. South Korea is also working to establish itself as a worldwide biotech centre.

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa make up the global pyrogen testing market. North America held the highest proportion of the worldwide pyrogen testing market in 2019. The high investment on pharmaceutical and biopharmaceutical research, increasing pharmaceutical drug pipelines, a growing number of drug approvals, and increased consumer awareness about product safety are all contributing to the North American pyrogen testing market's growth.

Charles River Laboratories, Inc. (US) Lonza (Switzerland) Merck KGaA (Germany) Thermo Fisher Scientific, Inc. (US) 

Comments

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area